| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05615818 | Personalized Medicine for Advanced Biliary Cancer Patients | Biliary Tract Neoplasms | Recruiting |
| Phase 2 | |||
| NCT05933395 | Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor | Advanced Breast Cancer | Recruiting |
| NCT06109467 | Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2… | GastroEsophageal Cancer | Recruiting |
| NCT04886531 | Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive… | Breast Cancer | Recruiting |
| NCT01042379 | I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer | Breast Neoplasms | Recruiting |
| NCT04374305 | Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related… | Neurofibromatosis Type 2 | Recruiting |
| NCT05564377 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced… | Advanced Malignant Solid Neoplasm | Recruiting |
| NCT06126276 | Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted… | Malignant Female Reproductive System Neoplasm | Recruiting |
| Phase 1/2 | |||
| NCT03919292 | Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca | Solid Tumor, Adult | Recruiting |
| NCT03377387 | Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast… | Breast Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT03065387 | Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT04502602 | Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced… | Advanced Solid Tumor | Active, Not Recruiting |